Dmitry Balyasny’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-93,678
Closed -$1.65M 2972
2026
Q1
$1.65M Sell
93,678
-506,784
-84% -$10.2M ﹤0.01% 1870
2025
Q4
$11.9M Sell
600,462
-1,030,358
-63% -$18.5M 0.02% 948
2025
Q3
$28.5M Buy
1,630,820
+882,028
+118% +$13.1M 0.04% 564
2025
Q2
$10.5M Buy
+748,792
New +$12.1M 0.02% 947
2025
Q1
Sell
-48,138
Closed -$542K 2753
2024
Q4
$542K Buy
+48,138
New +$563K ﹤0.01% 2170
2024
Q3
Sell
-10,442
Closed -$81.7K 2703
2024
Q2
$81.7K Buy
+10,442
New +$68.2K ﹤0.01% 2414
2022
Q2
Sell
-14,987
Closed -$168K 2710
2022
Q1
$168K Buy
+14,987
New +$135K ﹤0.01% 2055

Other funds holding ALHC

Dmitry Balyasny's ALHC Position: Q2 2026 in Review

Dmitry Balyasny sold out of Alignment Healthcare (ALHC) in Q2 2026, closing a stake of 93,678 shares — an estimated $1.65M sold.

Dmitry Balyasny first reported a position in ALHC in Q1 2022 and held it in 7 quarters. The position peaked at $28.5M in Q3 2025. 321 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Dmitry Balyasny reported no remaining Alignment Healthcare position as of Q2 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 93,678 Alignment Healthcare shares in Q2 2026, an estimated $1.65M.
  • Dmitry Balyasny first reported a position in Alignment Healthcare in Q1 2022 and held it in 7 quarters.
  • Dmitry Balyasny's Alignment Healthcare position peaked at $28.5M in Q3 2025.
  • 321 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.